BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the 25th Annual Oppenheimer Healthcare Conference being held December 10-11, 2014 at the Crowne Plaza Hotel in New York City. The Company is scheduled to present on Wednesday, December 10 at 10:20am (ET) and will provide a corporate update on the KALBITOR® (ecallantide) business, DX-2930 and the Licensing and Funded Research Portfolio (LFRP).
Help employers find you! Check out all the jobs and post your resume.
